rosiglitazone has been researched along with Reperfusion Injury in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (48.00) | 29.6817 |
| 2010's | 12 (48.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Li, X; Wang, R; Xu, Y; Yang, M | 1 |
| Chen, J; Chen, Z; Cui, Q; Geng, B; Meng, Y; Wang, J; Yang, J; Yang, W | 1 |
| Adeyi, OA; Echeverri, J; Farrokhi, K; Ganesh, S; Hamar, M; Kaths, JM; Kollmann, D; Linares, I; Selzner, M; Selzner, N; Urbanellis, P; Yip, P | 1 |
| Chen, J; Liu, H; Zhang, X | 1 |
| Cui, MM; Dai, CX; Ding, X; Fu, YY; Guo, MY; Li, M; Li, ZL; Qi, DS; Song, YJ; Wang, CL; Wang, YL; Wen, XR; Zhao, XF | 1 |
| Feng, D; Li, Y; Liu, D; Ning, S; Sun, R; Tian, D; Tian, X; Wang, Z; Yao, J; Zhang, F; Zhao, Y | 1 |
| Al Rouq, F; El Eter, E | 1 |
| Guo, F; Liu, L; Song, W; Wang, Q; Xiong, L; Yang, R; Zhong, H | 1 |
| Li, Z; Tian, Y; Zhai, D; Zhang, J; Zheng, Q | 1 |
| Lin, TN; Wu, JS; Wu, KK | 1 |
| Cheng, Y; Liang, H; Sun, GM; Sun, L; Xu, YW | 1 |
| Boerman, OC; Meijer, P; Oyen, WJ; Rennings, AJ; Rongen, GA; Smits, P; Tack, CJ; van Uden, DJ | 1 |
| Cheng, FC; Cheng, SM; Chou, CC; Chuang, HC; Lee, MR; Sheu, WH | 1 |
| Bhandari, S; Semple, DJ; Seymour, AM | 1 |
| Brookes, ZL; Huang, L; Nauli, SM; Ong, AC; Prasad, S; Ruff, L; Solanky, T; Upadhyay, VS | 1 |
| Caputi, AP; Chatterjee, PK; Cuzzocrea, S; Di Paola, R; Di Rosa, M; Dugo, L; Genovese, T; Ianaro, A; Patel, NS; Pisano, B; Thiemermann, C | 1 |
| Naito, Y; Yoshikawa, T | 1 |
| de la Lastra, CA; Martín, AR; Toma, W; Villegas, I | 1 |
| Chen, JJ; Cheung, WM; Lin, H; Lin, TN; Liou, JY; Shyue, SK; Wu, JS; Wu, KK | 1 |
| Aragno, M; Collino, M; Danni, O; Dianzani, C; Fantozzi, R; Gallicchio, M; Mastrocola, R; Rosa, AC; Thiemermann, C | 1 |
| Chen, J; Mehta, JL; Molavi, B | 1 |
| Sun, F; Xiang, J; Xiong, N; Zhao, H | 1 |
| Blanchard, J; Eismann, T; Galloway, E; Huber, N; Kuboki, S; Lentsch, AB; Schuster, R; Shin, T; Zingarelli, B | 1 |
| Egea, J; García, AG; López, MG; Martínez, A; Rosa, AO | 1 |
| Blumberg, RS; Kadowaki, T; Kubota, N; Matsuhashi, N; Miki, H; Nagai, R; Nakajima, A; Nakajima, N; Ohnishi, S; Saubermann, LJ; Terauchi, Y; Wada, K | 1 |
1 review(s) available for rosiglitazone and Reperfusion Injury
| Article | Year |
|---|---|
Thiazolidinediones: a new class of drugs for the therapy of ischemia-reperfusion injury.
Topics: Animals; Anti-Inflammatory Agents; Chromans; Humans; Ligands; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Reperfusion Injury; Rosiglitazone; Thiazolidinediones; Transcription Factors; Troglitazone | 2004 |
1 trial(s) available for rosiglitazone and Reperfusion Injury
| Article | Year |
|---|---|
Rosiglitazone reduces ischaemia-reperfusion injury in patients with the metabolic syndrome.
Topics: Double-Blind Method; Forearm; Humans; Insulin Resistance; Ischemia; Metabolic Syndrome; Muscle, Skeletal; Radionuclide Imaging; Reperfusion Injury; Rosiglitazone; Thiazolidinediones; Vasodilator Agents | 2010 |
23 other study(ies) available for rosiglitazone and Reperfusion Injury
| Article | Year |
|---|---|
Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
Topics: A549 Cells; Animals; Cell Death; Cell Line, Tumor; Coenzyme A Ligases; Disease Models, Animal; Epithelial Cells; Ferroptosis; Glutathione; Humans; Lipid Peroxidation; Lung; Lung Injury; Male; Mice; Mice, Inbred C57BL; Mitochondria; Phospholipid Hydroperoxide Glutathione Peroxidase; Reperfusion Injury; Rosiglitazone | 2020 |
FAM3A mediates PPARγ's protection in liver ischemia-reperfusion injury by activating Akt survival pathway and repressing inflammation and oxidative stress.
Topics: Animals; Apoptosis; Cell Survival; Cytokines; Disease Models, Animal; Disease Progression; Gene Expression; Hepatocytes; Liver Diseases; Liver Function Tests; Male; Mice; Mice, Knockout; Oxidative Stress; PPAR gamma; Protein Transport; Proto-Oncogene Proteins c-akt; Reperfusion Injury; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2017 |
PPAR-gamma activation is associated with reduced liver ischemia-reperfusion injury and altered tissue-resident macrophages polarization in a mouse model.
Topics: Alanine Transaminase; Anilides; Animals; Apoptosis; Aspartate Aminotransferases; Cell Polarity; Cytokines; Disease Models, Animal; Kupffer Cells; Lectins, C-Type; Liver; Male; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred C57BL; Necrosis; Nitric Oxide; PPAR gamma; Receptors, Cell Surface; Reperfusion Injury; Rosiglitazone; Thiazolidinediones | 2018 |
[Protective effects of rosiglitazone on hepatic ischemia reperfusion injury in rats].
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Catalase; Disease Models, Animal; Glutathione Peroxidase; L-Lactate Dehydrogenase; Ligation; Liver; Malondialdehyde; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones | 2018 |
The potential role of HO-1 in regulating the MLK3-MKK7-JNK3 module scaffolded by JIP1 during cerebral ischemia/reperfusion in rats.
Topics: Adaptor Proteins, Signal Transducing; Animals; Brain Ischemia; CA1 Region, Hippocampal; Cell Death; Disease Models, Animal; Down-Regulation; Heme Oxygenase (Decyclizing); Male; MAP Kinase Kinase Kinases; Maze Learning; Mitogen-Activated Protein Kinase 10; Mitogen-Activated Protein Kinase Kinase Kinase 11; Mitogen-Activated Protein Kinases; Neurons; Neuroprotection; Neuroprotective Agents; Phosphorylation; Proto-Oncogene Proteins c-jun; Rats, Sprague-Dawley; Reperfusion Injury; Rosiglitazone | 2019 |
Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.
Topics: Animals; Caco-2 Cells; Cell Line, Tumor; Coenzyme A Ligases; DNA-Binding Proteins; Ferroptosis; Humans; Intestines; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Models, Animal; Promoter Regions, Genetic; Quinoxalines; Reactive Oxygen Species; Reperfusion Injury; Rosiglitazone; Sp1 Transcription Factor; Spiro Compounds | 2019 |
PPAR-γ activator induces neuroprotection in hypercholesterolemic rats subjected to global cerebral ischemia/reperfusion injury: in vivo and in vitro inhibition of oxidative stress.
Topics: Animals; Brain Edema; Brain Ischemia; Dose-Response Relationship, Drug; Glutathione; Hypercholesterolemia; Interleukin-6; Lipid Peroxidation; Male; Neuroprotective Agents; Oxidative Stress; Peroxidase; PPAR gamma; Rats; Rats, Wistar; Reperfusion Injury; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2014 |
Therapeutic window of globular adiponectin against cerebral ischemia in diabetic mice: the role of dynamic alteration of adiponectin/adiponectin receptor expression.
Topics: Adiponectin; Animals; Apoptosis; Brain Ischemia; Caspase 12; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; eIF-2 Kinase; Endoplasmic Reticulum Chaperone BiP; Gene Expression Regulation; Heat-Shock Proteins; Humans; Hypoglycemic Agents; Injections, Intraventricular; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Protein Serine-Threonine Kinases; Receptors, Adiponectin; Reperfusion Injury; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factor CHOP | 2015 |
Significance of rosiglitazone inhibiting TLR4 expression in partial hepatic ischemia/reperfusion of mice.
Topics: Animals; Down-Regulation; Ligands; Liver; Male; Mice; Mice, Inbred BALB C; PPAR gamma; Random Allocation; Reperfusion Injury; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Toll-Like Receptor 4 | 2008 |
Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Anilides; Animals; Apoptosis; bcl-Associated Death Protein; bcl-X Protein; Caspase 3; Caspase 9; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cytochromes c; Cytoprotection; Dose-Response Relationship, Drug; Glucose; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Mice; Mitochondria; Neuroblastoma; Phosphorylation; Poly(ADP-ribose) Polymerases; PPAR gamma; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Reperfusion Injury; RNA Interference; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Time Factors; Transfection; Up-Regulation | 2009 |
12/15-Lipoxygenase inhibitor baicalein suppresses PPAR gamma expression and nuclear translocation induced by cerebral ischemia/reperfusion.
Topics: Anilides; Animals; Antioxidants; Cell Nucleus; Cerebral Cortex; Cytosol; Disease Models, Animal; Flavanones; Hypoglycemic Agents; Infarction, Middle Cerebral Artery; Male; PPAR gamma; Protein Transport; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rosiglitazone; Thiazolidinediones; Time Factors; Up-Regulation | 2010 |
Microdialysis combined blood sampling technique for the determination of rosiglitazone and glucose in brain and blood of gerbils subjected to cerebral ischemia.
Topics: Animals; Automation, Laboratory; Blood Glucose; Brain; Brain Infarction; Brain Ischemia; Gerbillinae; Glucose; Half-Life; Hypoglycemic Agents; Limit of Detection; Male; Microdialysis; PPAR gamma; Random Allocation; Reperfusion Injury; Reproducibility of Results; Rosiglitazone; Tandem Mass Spectrometry; Thiazolidinediones; Tissue Distribution | 2011 |
Uremic cardiomyopathy is characterized by loss of the cardioprotective effects of insulin.
Topics: Animals; Cardiomyopathies; Cardiotonic Agents; Disease Models, Animal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rosiglitazone; Thiazolidinediones; Uremia | 2012 |
Pkd2 mesenteric vessels exhibit a primary defect in endothelium-dependent vasodilatation restored by rosiglitazone.
Topics: Animals; Antioxidants; Arterioles; Calcium; Capillary Permeability; Cells, Cultured; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Genotype; Heterozygote; Hypertension; Male; Mesentery; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Myography; Nitric Oxide; Oxidative Stress; Peroxynitrous Acid; Phenotype; Polycystic Kidney, Autosomal Dominant; PPAR gamma; Renal Insufficiency; Reperfusion Injury; Rosiglitazone; Superoxides; Thiazolidinediones; Time Factors; TRPP Cation Channels; Vasodilation; Vasodilator Agents; Venules | 2013 |
Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
Topics: Animals; Benzhydryl Compounds; Blood Pressure; Epoxy Compounds; Immunologic Factors; Intercellular Adhesion Molecule-1; Interleukin-1; Intestinal Mucosa; Intestines; Ligands; Male; Malondialdehyde; Peroxidase; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Reperfusion Injury; Rosiglitazone; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha; Tyrosine; Vasodilator Agents | 2003 |
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation.
Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Gastric Mucosa; Glutathione Peroxidase; Immunohistochemistry; Male; Membrane Proteins; Necrosis; Neutrophils; Oxidative Stress; Peroxidase; PPAR gamma; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Rosiglitazone; Stomach; Superoxide Dismutase; Thiazolidinediones; Tumor Necrosis Factor-alpha; Up-Regulation; Xanthine Oxidase | 2004 |
15d-prostaglandin J2 protects brain from ischemia-reperfusion injury.
Topics: Adenoviridae; Animals; Apoptosis; Caspase 3; Caspases; Cells, Cultured; Cyclooxygenase 1; Gene Transfer Techniques; Genetic Therapy; Heme Oxygenase-1; Infarction, Middle Cerebral Artery; Male; Necrosis; Neurons; Neuroprotective Agents; PPAR gamma; Prostaglandin D2; Rats; Rats, Long-Evans; Reperfusion Injury; Rosiglitazone; Thiazolidinediones; Vasodilator Agents | 2006 |
Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion.
Topics: Animals; Brain Ischemia; Cyclooxygenase 2; Hippocampus; Inflammation; Injections, Intravenous; Lipid Peroxidation; Male; Mitogen-Activated Protein Kinases; NF-kappa B; Oxidative Stress; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Reperfusion Injury; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2006 |
Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Glucose; Cardiotonic Agents; Enzyme Inhibitors; Hemodynamics; Hypoglycemic Agents; Immunohistochemistry; Ligands; Male; Mitogen-Activated Protein Kinase 1; Myocardial Infarction; Myocardium; PPAR gamma; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones | 2006 |
Effect of Rosiglitazone Maleate on inflammation following cerebral ischemia/reperfusion in rats.
Topics: Animals; Brain; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Inflammation; Interleukin-6; Male; Neuroprotective Agents; Rats; Rats, Wistar; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones | 2007 |
Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice.
Topics: Animals; C-Peptide; E1A-Associated p300 Protein; Gene Expression Regulation; Hepatocytes; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; PPAR gamma; Prostaglandin D2; Reperfusion Injury; Retinoid X Receptor alpha; Rosiglitazone; Thiazolidinediones | 2008 |
Neuroprotective effect of the new thiadiazolidinone NP00111 against oxygen-glucose deprivation in rat hippocampal slices: implication of ERK1/2 and PPARgamma receptors.
Topics: Anilides; Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Glucose; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Hypoxia-Ischemia, Brain; L-Lactate Dehydrogenase; Male; MAP Kinase Signaling System; Neuroprotective Agents; Organ Culture Techniques; Phosphorylation; PPAR gamma; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Rosiglitazone; Thiadiazoles; Thiazolidinediones | 2008 |
Endogenous PPAR gamma mediates anti-inflammatory activity in murine ischemia-reperfusion injury.
Topics: Animals; Cells, Cultured; Colitis; Epithelial Cells; Gastric Mucosa; Gene Expression; Hypoglycemic Agents; In Vitro Techniques; Intercellular Adhesion Molecule-1; Interleukin-8; Intestinal Mucosa; L-Lactate Dehydrogenase; Liver; Mice; Mice, Inbred BALB C; Mice, Knockout; NF-kappa B; Peroxidase; Pneumonia; Receptors, Cytoplasmic and Nuclear; Reperfusion Injury; RNA, Messenger; Rosiglitazone; Stomach; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha | 2001 |